Ardent Health Partners (NYSE:ARDT) Hits New 12-Month Low - Here's Why

Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) reached a new 52-week low during trading on Friday . The company traded as low as $13.07 and last traded at $13.16, with a volume of 591743 shares. The stock had previously closed at $13.93.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Truist Financial decreased their target price on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Morgan Stanley reduced their price objective on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 21st. Royal Bank of Canada dropped their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Tuesday, March 4th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Finally, Stephens reissued an "overweight" rating and set a $22.00 price objective on shares of Ardent Health Partners in a report on Thursday, February 27th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $21.18.

Ardent Health Partners Trading Down 1.1 %

The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The company's 50-day simple moving average is $14.47 and its 200-day simple moving average is $16.37.

Remove Ads

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion. On average, research analysts forecast that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Institutional Investors Weigh In On Ardent Health Partners

Large investors have recently modified their holdings of the stock. Charles Schwab Investment Management Inc. acquired a new stake in Ardent Health Partners in the third quarter valued at $526,000. BNP Paribas Financial Markets bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth about $42,000. MetLife Investment Management LLC bought a new position in shares of Ardent Health Partners during the third quarter worth about $135,000. Goldentree Asset Management LP acquired a new position in Ardent Health Partners in the third quarter worth about $22,897,000. Finally, Centiva Capital LP bought a new stake in Ardent Health Partners in the third quarter valued at about $469,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.